Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006400
Filing Date
2024-11-12
Accepted
2024-11-12 09:31:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 IMMUNIC, INC. p24-3091sc13g.htm SC 13G 75856
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-3091ex99.htm EX-99.1 3199
  Complete submission text file 0000902664-24-006400.txt   80737
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88651 | Film No.: 241444197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G